Skip to main content

Table 1 Seroprevalence and result of QuantiFERON®-TB assay of the studied transmissible infections in Emirati medical students

From: Seroprevalence of measles, mumps, rubella, varicella–zoster and hepatitis A–C in Emirati medical students

Results Rubella1 Measles2 Mumps3 HAV4 HBV5 HCV4 VZ6 HIV7 QuantiFERON®-TB7
Positive (%) 96.5 54 84 21 48 0 88 0 8
Equivocal (%) 3 18 10 - - - 5 - 2
Negative (%) 0.5 28 6 79 52 100 7 100 90
  1. 1A positive result is >10 IU/mL, equivocal 5.0 to 9.9 IU/mL, and negative 0.0 to 4.9 IU/mL. Results were available in 181 (69%) of 261 students.
  2. 2A positive result is >0.70 relative fluorescence value (RFV), equivocal >0.50 to <0.70 RFV, and negative <0.50 RFV. Results were available in 180 (69%) of 261 students.
  3. 3A positive result is >0.50 RFV, equivocal >0.35 to <0.50 RFV, and negative <0.35 RFV. Mumps serology was available in 170 (65%) of 261 students.
  4. 4A reactive test is >1.0 relative light unit (RLU) and nonreactive <1.0 RLU. Results were available in 168 (64%) of 261 students.
  5. 5A reactive test is >10.0 mIU/mL and nonreactive <10.0 mIU/mL. Results were available for 181(69%) of 261 students.
  6. 6A positive result is >0.90 RFV, equivocal 0.60 to <0.90 RFV, and negative <0.60 RFV. The titer was available in 182 (70%) of 261 students.
  7. 7Please refer to the manufactures’ brochures. Results were available only in 182 (70%) of 261 students. Equivocal test indicates indeterminate.
  8. Positive tests for HAV, HBV, HCV and HIV indicate reactive and negative tests indicate non-reactive.